ORP-3R

ORP-3R is a synthetic peptide developed for laboratory research as a triple receptor agonist, meaning a single molecule engineered to bind and activate three distinct receptor targets rather than one. It is investigated in research models for activity at the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). Because all three receptors belong to the same proglucagon-derived peptide family, ORP-3R is used by researchers to study how a single compound behaves across multiple related signaling pathways in one experimental system. It is supplied strictly for laboratory research use, not for human or animal consumption.

Research interest in ORP-3R centers on its multi-receptor pharmacology. Each of the three receptors it engages, GLP-1R, GIPR, and GCGR, is a class B G protein-coupled receptor that signals primarily through adenylate cyclase and cyclic AMP production when activated. Laboratory studies on ORP-3R examine receptor binding affinity, activation kinetics, and downstream second-messenger signaling at each receptor individually, as well as how simultaneous engagement of all three may alter the overall signaling profile compared to single-receptor activation.

As a triple receptor agonist, ORP-3R is studied alongside single- and dual-receptor peptide analogs to characterize structure-activity relationships across the incretin and glucagon receptor family. Comparative in-vitro assays assess relative potency and selectivity at each receptor, while receptor internalization and desensitization studies explore how prolonged or repeated exposure affects receptor availability in cell-based systems. This research framework positions ORP-3R as a reference compound for investigating multi-receptor agonism as a pharmacological strategy, distinct from mono-agonist peptides that target only one of these three receptors.

Because the GLP-1, GIP, and glucagon receptors are each implicated in distinct aspects of energy balance and glucose-regulatory signaling, ORP-3R is used in preclinical and in-vitro research to map how combined activation of these pathways is coordinated at the cellular level. Studies in this area typically rely on isolated cell lines expressing one or more of the target receptors, as well as rodent models used to characterize receptor pharmacology and signaling cascades. This research is exploratory and mechanistic in nature, intended to inform the broader scientific understanding of multi-receptor incretin and glucagon-family biology.

ORP-3R is compounded by a licensed U.S. pharmacy and distributed by Optimum ReGen Peptides exclusively for qualified laboratory research. Every batch is analyzed by an independent third-party laboratory using analytical methods such as high-performance liquid chromatography and mass spectrometry to confirm peptide identity and purity, with a certificate of analysis provided for each lot.

ORP-3R is supplied as a lyophilized, freeze-dried powder intended for reconstitution in a laboratory setting prior to use in cell-based or preclinical experimental protocols. Researchers should follow the storage and handling guidance provided with each shipment and accompanying certificate of analysis to preserve peptide stability between receipt and use.

ORP-3R is sold exclusively for laboratory research use by qualified professionals and institutions. It is not approved, and not intended, for human or animal consumption, and no health or disease-related claims are made about it. This listing is provided for research and informational purposes only and does not constitute medical advice.

ORP-3R is in stock and available to buy online from Optimum ReGen Peptides — a real American research-peptide company with a physical storefront in Medford, Oregon, not an anonymous overseas dropshipper. Priced from $75, every order ships within two business days, flat $13 nationwide, in plain discreet packaging with tracking.

As your ORP-3R supplier we back every batch with a third-party certificate of analysis and compound in a licensed US 503A pharmacy. Vials are supplied lyophilized at analytical purity for laboratory and research use only, not for human consumption.

In laboratory research, incretin and glucagon receptor peptides are typically studied using heterologous expression systems in which the relevant receptor is expressed in cell lines (e.g., HEK293 or CHO cells), and peptide binding and receptor activation are assessed via cAMP accumulation assays, radioligand binding, or BRET-based biosensors.

Preclinical metabolic studies use rodent models of glucose challenge or metabolic perturbation to assess effects on insulin secretion, energy expenditure, and substrate handling. ORP-3R is of particular interest as a tool for comparing triple-pathway activity against single- and dual-agonist reference compounds.